Lactobacillus Rhamnosus

Lactobacillus Rhamnosus is a species of gram-positive, facultative anaerobic, non-spore-forming rod-shaped bacteria that belongs to the genus Lactobacillus. Originally classified as a subspecies of L. casei, it was later identified as a distinct species and has since become one of the most extensively researched probiotic strains in clinical science. First isolated in 1983 by researchers Sherwood Gorbach and Barry Goldin—leading to the famous “GG” strain designation—it is uniquely characterized by its ability to survive the harsh acidic environment of the human stomach and its high affinity for adhering to the intestinal mucosa.

Clinical Benefits & Mechanism of Action

Lactobacillus rhamnosus functions through several complex physiological pathways that impact both local gastrointestinal health and systemic neurological function:

1.  Gut-Brain Axis Modulation: It interacts naturally with the central nervous system via the vagus nerve pathway. Specific strains have been shown to support the normal expression of GABA receptors in the hippocampus and amygdala, helping to maintain healthy baseline corticosterone levels and promoting a calm, stable emotional state.
2.  Enhancement of Epithelial Barrier Function: It promotes the natural expression of tight junction proteins, such as occludin and zonula occludens-1 (ZO-1). This strengthens the intestinal wall, supporting normal intestinal permeability to manage the healthy retention of lipopolysaccharides (LPS) within the digestive tract and maintain systemic metabolic balance.
3.  Cytokine Regulation: It exerts immunomodulatory effects by supporting the production of anti-inflammatory signaling molecules (such as IL-10) and regulatory T-cells, while simultaneously promoting a healthy, balanced baseline of pro-inflammatory cytokines like TNF-alpha and IL-6.
4.  Competitive Balance of Microflora: Through the natural production of biosurfactants and lactic acid, it optimizes the local environment to support beneficial flora and assist the body’s natural mucosal defenses against unwelcome microflora species like E. coli and Salmonella.
5.  Short-Chain Fatty Acid (SCFA) Production: It contributes to the natural fermentation of dietary fibers into SCFAs like butyrate and acetate, which serve as the primary energy source for colonocytes and support normal cellular signaling.

Scientific Sources & Clinical Trials

• The Assessment of Multidimensional Clinical, Biological and Patient-Reported Outcomes to Evaluate the Efficacy of Add-On Lactobacillus rhamnosus GG Supplementation in Mild Ulcerative Colitis: A Randomized Pilot Trial.
• Evaluation of the Effects of an Immune-Boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
• Effects of UDCA and probiotics on metabolic outcomes in type 2 diabetes patients on metformin: A randomized trial in Bosnia and Herzegovina.